Advertisement
Strategies should be adopted to help with implementation of the Choosing Wisely program

Choosing Wisely: How to Implement in Clinical Practice

0
Strategies to improve chance of success include familiarization with evidence behind recs
Measures can be taken to encourage patients to use patient portals to help ensure practices meet current Stage 2 meaningful use requirements

AMA Suggests Ways to Encourage Use of Patient Portals

0
Suggestions include training staff on portal use; showing patients how to use the portal
Use of an arts observation curriculum can help students learn to observe objectively and articulate their observations

Arts Observation Curriculum May Be Beneficial for Medical Students

0
Learning to observe objectively and communicate observations important in clinical practice
Among institutional review board members

Progress in Reporting Conflict of Interest Among IRB Members

0
Percentage of members who felt another member didn't disclose financial relationships down '05 to '14
For overweight adults with diabetes mellitus

Lifestyle Intervention Can Ward Off Obesity-Related Knee Pain

0
Findings show benefit at one year for overweight adults with diabetes mellitus at high risk of knee pain
Weight loss is a strong predictor of mortality in patients with rheumatoid arthritis

Weight Loss Predicts Mortality in Rheumatoid Arthritis

0
Highest risk seen with high annual weight loss rate, low BMI in previously obese
For patients with systemic lupus erythematosus

Vitamin D Shows No Impact on Interferon Response in SLE

0
No change in interferon signature in vitamin D-deficient patients, those with vitamin D repletion
The U.S Food and Drug Administration on Thursday strengthened the warning labels for non-aspirin nonsteroidal anti-inflammatory drugs

FDA Strengthens Heart Attack, Stroke Warning for NSAIDs

0
Aspirin not included in alert
Patients with inflammatory arthritis want to be informed about multiple current and future treatment options

Arthritis Patients Want Info About Multiple Drug Options

0
Patients with inflammatory arthritis want to be informed about current, future treatment options
Rituximab retreatment at clinical relapse is at least as cost-effective as a more intensive regimen in longstanding rheumatoid arthritis

Rituximab Retreatment at Clinical Relapse Cost-Effective in RA

0
At least as cost-effective as more intensive regimen in patients with longstanding RA